# PepGen Inc.: filings

PEPG · Nasdaq · CIK 1835597 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/pepg.md) · [Financials](/companies/pepg/financials.md) · [Filings](/companies/pepg/filings.md) · [Insiders](/companies/pepg/insiders.md)

## Reports and events: 96 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 98, 8-K 65, 3 21, 10-Q 14, SCHEDULE 13G/A 9, CORRESP 8, SC 13G 7, SC 13G/A 7, UPLOAD 7, EFFECT 5, S-8 5, SCHEDULE 13G 5, 10-K 4, 144 4, 424B5 4, ARS 4, DEF 14A 4, DEFA14A 4, S-3 3, SC 13D/A 3, D 2, DRS 2, DRS/A 2, DRSLTR 2, S-1/A 2, SEC STAFF LETTER 2, 10-K/A 1, 3/A 1, 424B4 1, 4/A 1, 8-A12B 1, CERT 1, POS AM 1, PRE 14A 1, S-1 1, SC 13D 1, SCHEDULE 13D/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-06 | 07:40 ET | [8-K](/filings/0001193125-26-336767.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-336767 |
| 2026-08-06 | 07:30 ET | [10-Q](/filings/0001193125-26-336754.md) | Quarterly report, period 2026-06-30 | 0001193125-26-336754 |
| 2026-06-22 | 16:30 ET | [8-K](/filings/0001193125-26-277579.md) | 5.07 Shareholder vote results | 0001193125-26-277579 |
| 2026-05-21 | 07:30 ET | [8-K](/filings/0001193125-26-233403.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-233403 |
| 2026-05-12 | 16:10 ET | [8-K](/filings/0001193125-26-219424.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-219424 |
| 2026-05-12 | 16:05 ET | [10-Q](/filings/0001193125-26-219375.md) | Quarterly report, period 2026-03-31 | 0001193125-26-219375 |
| 2026-04-28 | 16:05 ET | [DEF 14A](/filings/0001193125-26-186927.md) | Proxy statement, period 2026-06-18 | 0001193125-26-186927 |
| 2026-03-30 | 17:30 ET | [8-K](/filings/0001193125-26-131786.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-131786 |
| 2026-03-04 | 17:02 ET | [8-K](/filings/0001193125-26-091784.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-091784 |
| 2026-03-04 | 16:15 ET | [10-K](/filings/0001193125-26-091536.md) | Annual report, period 2025-12-31 | 0001193125-26-091536 |
| 2026-03-04 | 16:11 ET | [8-K](/filings/0001193125-26-091503.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-091503 |
| 2025-12-08 | 07:00 ET | [8-K](/filings/0001193125-25-310544.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-310544 |
| 2025-11-12 | 08:02 ET | [8-K](/filings/0001193125-25-276019.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-276019 |
| 2025-11-12 | 08:00 ET | [10-Q](/filings/0001193125-25-276001.md) | Quarterly report, period 2025-09-30 | 0001193125-25-276001 |
| 2025-11-07 | 08:00 ET | [8-K](/filings/0001193125-25-271089.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-271089 |
| 2025-10-01 | 16:05 ET | [8-K](/filings/0001193125-25-226746.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-226746 |
| 2025-09-30 | 16:36 ET | [SCHEDULE 13D/A](/filings/0001346824-25-000009.md) | Ownership report, active investor, amended | 0001346824-25-000009 |
| 2025-09-26 | 07:00 ET | [8-K](/filings/0001193125-25-218503.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-218503 |
| 2025-09-24 | 16:21 ET | [8-K](/filings/0001193125-25-215435.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-215435 |
| 2025-08-07 | 08:02 ET | [8-K](/filings/0001193125-25-174982.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-174982 |
| 2025-08-07 | 08:00 ET | [10-Q](/filings/0001193125-25-174979.md) | Quarterly report, period 2025-06-30 | 0001193125-25-174979 |
| 2025-06-06 | 08:29 ET | [8-K](/filings/0000950170-25-082707.md) | 5.07 Shareholder vote results | 0000950170-25-082707 |
| 2025-05-28 | 17:11 ET | [8-K](/filings/0000950170-25-078428.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-078428 |
| 2025-05-08 | 08:05 ET | [8-K](/filings/0000950170-25-066419.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-066419 |
| 2025-05-08 | 08:00 ET | [10-Q](/filings/0000950170-25-066414.md) | Quarterly report, period 2025-03-31 | 0000950170-25-066414 |
| 2025-04-25 | 08:00 ET | [DEF 14A](/filings/0000950170-25-058337.md) | Proxy statement, period 2025-06-04 | 0000950170-25-058337 |
| 2025-03-31 | 16:05 ET | [8-K](/filings/0000950170-25-047690.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-25-047690 |
| 2025-03-28 | 16:00 ET | [8-K](/filings/0000950170-25-046746.md) | 5.02 Departure or appointment of officers or directors | 0000950170-25-046746 |
| 2025-03-04 | 08:45 ET | [8-K](/filings/0000950170-25-031337.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-031337 |
| 2025-02-24 | 07:43 ET | [8-K](/filings/0000950170-25-025232.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-025232 |
| 2025-02-24 | 07:00 ET | [10-K](/filings/0000950170-25-025226.md) | Annual report, period 2024-12-31 | 0000950170-25-025226 |
| 2025-01-29 | 16:19 ET | [8-K](/filings/0000950170-25-010515.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-010515 |
| 2024-12-16 | 08:00 ET | [8-K](/filings/0000950170-24-136389.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-136389 |
| 2024-11-07 | 08:02 ET | [10-Q](/filings/0000950170-24-122821.md) | Quarterly report, period 2024-09-30 | 0000950170-24-122821 |
| 2024-11-07 | 08:00 ET | [8-K](/filings/0000950170-24-122815.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-122815 |
| 2024-10-08 | 08:27 ET | [8-K](/filings/0000950170-24-113410.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-113410 |
| 2024-09-19 | 16:30 ET | [8-K](/filings/0000950170-24-108126.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-108126 |
| 2024-08-20 | 08:10 ET | [8-K](/filings/0000950170-24-098860.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-098860 |
| 2024-08-08 | 08:05 ET | [10-Q](/filings/0000950170-24-093351.md) | Quarterly report, period 2024-06-30 | 0000950170-24-093351 |
| 2024-08-08 | 08:01 ET | [8-K](/filings/0000950170-24-093348.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-093348 |
| 2024-07-30 | 16:55 ET | [8-K](/filings/0001193125-24-188977.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-188977 |
| 2024-07-02 | 08:16 ET | [8-K](/filings/0000950170-24-080021.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-080021 |
| 2024-06-20 | 17:23 ET | [8-K](/filings/0001193125-24-164587.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-24-164587 |
| 2024-06-11 | 08:00 ET | [8-K](/filings/0000950170-24-071617.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-071617 |
| 2024-05-14 | 16:05 ET | [10-Q](/filings/0000950170-24-059519.md) | Quarterly report, period 2024-03-31 | 0000950170-24-059519 |
| 2024-05-14 | 16:01 ET | [8-K](/filings/0000950170-24-059485.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-059485 |
| 2024-04-26 | 16:05 ET | [DEF 14A](/filings/0000950170-24-049083.md) | Proxy statement, period 2024-06-20 | 0000950170-24-049083 |
| 2024-03-29 | 08:15 ET | [10-K/A](/filings/0000950170-24-038417.md) | Annual report, amended, period 2023-12-31 | 0000950170-24-038417 |
| 2024-03-15 | 16:01 ET | [8-K](/filings/0001193125-24-069110.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-24-069110 |
| 2024-03-13 | 07:20 ET | [8-K](/filings/0000950170-24-030505.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-030505 |

Page 1 of 2. [Older](/companies/pepg/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.